Integrating personalized skin cancer risk feedback in community health centers
A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers
This study is looking to help people understand their personal risk for skin cancer based on their genes, so they can make better choices about sun safety and skin checks, especially in community health centers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10936380 on NIH RePORTER |
What this research studies
This research aims to improve skin cancer prevention by providing personalized genetic risk feedback to diverse adult populations in federally qualified health centers. It focuses on educating patients about their risk factors related to skin cancer, particularly those linked to genetic variations. The study will evaluate how effectively this information can motivate individuals to adopt preventive behaviors, such as reducing sun exposure and increasing skin examinations. By engaging with community health settings, the research seeks to identify barriers and facilitators to implementing these interventions effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults from diverse backgrounds who are at risk for skin cancer and receive care at community health centers.
Not a fit: Patients who do not have access to community health centers or those who are not at risk for skin cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased awareness and adoption of skin cancer prevention strategies among at-risk populations.
How similar studies have performed: Previous interventions using genetic risk feedback for skin cancer prevention have shown promising results, indicating that this approach has potential for success.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Kanetsky, Peter a — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Kanetsky, Peter a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.